← Eichor
Study identifier: NCT04620642 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Lyon Registry of Stroke Treated by Thrombolysis or Thrombectomy

Condition: Ischemic Stroke  ·  Sponsor: Hospices Civils de Lyon

PhaseN/A
Planned participants4500
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This observational study as an objective of characterizing the population of patients treated within the neurovascular unit of the Pierre Wertheimer hospital (Hospices Civils de Lyon) in order to determine their phenotype (age, sex, risk factors, etc.) and its evolution over time. It also aims to assess the management of ischemic stroke (IS) in the neurovascular unit of Pierre Wertheimer Hospital. We will assess in particular the pre-hospital and hospital care times, the type of medical care (thrombolysis and / or thrombectomy) as well as the efficiency of this care (effective recanalization, outcome of patient, etc.).

This description comes directly from the study's public registry record.

Talk to the study team

Tae Hee CHO, MD  ·  0033 4 72 35 78 07  ·  tae-hee.cho@chu-lyon.fr

MArielle BUISSON  ·  0033 4 72 35 71 70  ·  marielle.buisson01@chu-lyon.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Hôpital Pierre Wertheimer, GHE, HCLLyon, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04620642